341 Studies Now Enrolling
Clinical Trials of Multivalent Opioid Vaccine Components (Group 1)
Clinical Trials of Multivalent Opioid Vaccine Components (Healthy individuals who use heroin or other opioids)
| Sponsor: | National Institute on Drug Abuse |
| Enrolling: | Male and Female Patients |
| Study Length: | 96 Weeks |
| Clinic Visits: | 33 |
| IRB Number: | 7712-1 |
| U.S. Govt. ID: | NCT04458545 |
| Contact: | Rachel Luba: 646-774-6243 / rrl2117@cumc.columbia.edu |
Additional Study Information:
Do you use Heroin or Opioids? Physically-dependent healthy individuals who use heroin or other opioids are needed for an outpatient research study at the New York State Psychiatric Institute. Earn up to $7,350 for your participation. Call 646-774-6243. Screening Procedures Include: 3-5 screening visits to determine eligibility ($75 per visit). If Eligible, Study Procedures Include: Regular study visits for 21 weeks , continued study visits from weeks 21-96 (every 4-6 weeks), regular assessment of physical health (ECG, vitals, bloodwork), Psychiatric Assessments, and Questions about side effects and new medications.
This study is closed
Do You Qualify?
| Are you currently using heroin or other opioids? | Yes | No |
| Are you between 18 and 59 years old? | Yes | No |
| Are you pregnant or breastfeeding? | Yes | No |
| Have you ever used opioids intranasally (through your nose)? | Yes | No |
| Are you willing to receive an experimental vaccine for opioid use disorder? | Yes | No |